Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

Saved in:
Bibliographic Details
Title: Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).
Authors: Tallantyre EC; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK; Department of Neurology, University Hospital of Wales, Cardiff, UK., Planchon SM; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, USA., Howard H; Research and Innovation, Nottingham University Hospitals NHS Trust, Nottingham, UK., Mays J; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, USA., Frowd N; Research and Innovation, Nottingham University Hospitals NHS Trust, Nottingham, UK., Cohen JA; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, USA., Coles A; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Hersh CM; Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, USA., Miller DM; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, USA., Dever M; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland, OH, USA., Gray EH; MS Society, London, UK., LaRocca NG; National MS Society, New York, NY, USA., Nakamura K; Department of Biomedical Engineering, Cleveland Clinic, Cleveland, OH, USA., Bale C; Person with MS, Nottingham., Covey-Crump G; Veterinary Studies, University of Bristol, Bristol, UK., Alvarez E; Rocky Mountain Multiple Sclerosis Center at the University of Colorado, Aurora, CO, USA., Arun T; Department of Neurosciences, University of Warwick, Coventry, UK; Neurology Clinical Reference Group, NHSE, London., Brownlee WJ; Department of Neuroinflammation, UCL Institute of Neurology, London, UK; NIHR University College London Hospitals Biomedical Research Centre, London, UK., Craner M; University of Oxford, Oxford, UK; Frimley Health Foundation Trust, Camberley., Freeman L; Dell Medical School, The University of Texas at Austin, Austin, TX, USA., Frost N; Department of Neurology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA., Goldman MD; Department of Neurology, Virginia Commonwealth University, Richmond, VA, USA., Gupta RK; Department of Neurology, UTHealth Houston, Houston, TX, USA., Harding KE; Department of Neurology, Aneurin Bevan University Health Board, Royal Gwent Hospital, Newport, UK., Hobart J; Clinical Neurology Research Group, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK., Hutton GJ; Maxine Mesinger Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine, Houston, TX, USA., Hyland MH; Department of Neurology, University of Rochester, Rochester, NY, USA., Kalra S; University Hospital North Staffordshire NHS Trust, Stoke-on-Trent, UK; Neuroscience and Neurology Group, School of Medicine, Keele University, Keele, UK., Kannan M; Atlanta Neuroscience Institute, Atlanta, GA, USA., Kantarci O; Department of Neurology, Mayo Clinic Rochester, Rochester, MN, USA., Lashley D; Clinical Neurology Research Group, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK., Lily O; Leeds Teaching Hospitals, Leeds, UK., Mahad D; Centre for Neurodegeneration, The University of Edinburgh, Edinburgh, UK., Nicholas JA; OhioHealth Multiple Sclerosis Center, Columbus, OH, USA; Riverside Methodist Hospital, Columbus, OH, USA., Nicholas R; Imperial College Healthcare NHS Trust, London, UK., Paling D; Department of Neurology, Royal Hallamshire Hospital, Sheffield, UK., Pearson OR; Swansea Bay University Health Board, Port Talbot, UK., Rice CM; Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Department of Neurology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK., Samudralwar R; Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA., Schmalstieg WF; Department of Neurology, University of Minnesota, Minneapolis, MN, USA., Singh M; Department of Neurology, University of Virginia, Charlottesville, VA, USA., Zune The E; Department of Neurology, University Hospitals of Leicester NHS Trust, Leicester, UK., Weinstock-Guttman B; Jacobs MS Center for Treatment and Research, School of Medicine and Biomedical Sciences, Buffalo, NY, USA., Zabeti A; University of Cincinnati Gardner Neuroscience Institute, Cincinnati, OH, USA., Love TE; Departments of Medicine and Population and Quantitative Health Sciences, CWRU School of Medicine, Population Health Research Institute, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA., Gunzler DD; Population Health Research Institute, The MetroHealth System, Case Western Reserve University, Cleveland, OH, USA., Liu Y; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Gerry S; Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Evangelou N; Division of Mental Health and Clinical Neuroscience, Medical School, University of Nottingham, Nottingham, UK., Ontaneda D; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Jun; Vol. 32 (7), pp. 722-736. Date of Electronic Publication: 2026 May 31.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Observational Study; Pragmatic Clinical Trial
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-0970
DOI:10.1177/13524585261449988